pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Experts warn protein restriction could harm older adults and GLP-1 patients

Aug 20, 2026·read at STAT ↗Negative

Researchers have recently suggested that limiting dietary protein might improve metabolic health and extend lifespan, a claim highlighted in a review paper in Cell Press Blue.

Nutrition specialists cautioned that such advice could be dangerous for older adults, people with sedentary lifestyles, and individuals taking GLP-1 weight‑loss medications, warning of serious health risks.

Stuart Phillips, a professor of kinesiology, dismissed the study as a "beautiful mouse story" being marketed as human guidance, noting that low protein intake in people over 65 is linked to poorer outcomes rather than benefits.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Reduce protein to increase longevity? Nutrition experts say that’s a bad idea”

read at STAT ↗
1,331 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2
drugs
Rare Disease2
topics
GLP-1 receptor6Endocrinology & Metabolism5Obesity2Rare Disease2CardiologyDuchenne Muscular DystrophyNephrologyType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77MFierce Biotech
  • Jul 31Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 failFierce Biotech
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 8Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsSTAT